NO974260L - Nye definerte enzymblandinger for oppnåelse av celler og behandling av sår - Google Patents
Nye definerte enzymblandinger for oppnåelse av celler og behandling av sårInfo
- Publication number
- NO974260L NO974260L NO974260A NO974260A NO974260L NO 974260 L NO974260 L NO 974260L NO 974260 A NO974260 A NO 974260A NO 974260 A NO974260 A NO 974260A NO 974260 L NO974260 L NO 974260L
- Authority
- NO
- Norway
- Prior art keywords
- newly defined
- treating wounds
- enzyme mixtures
- mixtures
- obtaining cells
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6424—Serine endopeptidases (3.4.21)
- C12N9/6448—Elastases, e.g. pancreatic elastase (3.4.21.36); leukocyte elastase (3.4.31.37)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/52—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dermatology (AREA)
- Enzymes And Modification Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Materials For Medical Uses (AREA)
Abstract
Anvendelsen av definert sammensatte blandinger av rensede enzymer fra Clostridium histolyticum til reproduserbar, standardisert utvinning av celler eller vevsfragmenter fra humane eller dyriske vev, samt disse enzymene og deres blandinger, beskrives. Dessuten beskrives den direkte eller indirekte medisinske anvendelse av disse enzymene, for seg eller som bestanddel av blandinger, f eks. ved sårbehandling.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19509584 | 1995-03-16 | ||
DE19532906A DE19532906A1 (de) | 1995-03-16 | 1995-09-07 | Neue, definierte Enzymmischungen zur Zellgewinnung und für die Wundbehandlung |
PCT/EP1996/001044 WO1996028543A1 (de) | 1995-03-16 | 1996-03-12 | Neue, definierte enzymmischungen zur zellgewinnung und für die wundbehandlung |
Publications (2)
Publication Number | Publication Date |
---|---|
NO974260D0 NO974260D0 (no) | 1997-09-15 |
NO974260L true NO974260L (no) | 1997-11-14 |
Family
ID=26013440
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO974260A NO974260L (no) | 1995-03-16 | 1997-09-15 | Nye definerte enzymblandinger for oppnåelse av celler og behandling av sår |
Country Status (13)
Country | Link |
---|---|
US (1) | US6146626A (no) |
EP (1) | EP0815211A1 (no) |
JP (1) | JPH11501517A (no) |
AU (1) | AU702514B2 (no) |
BR (1) | BR9607143A (no) |
CA (1) | CA2213723A1 (no) |
CZ (1) | CZ280397A3 (no) |
EA (1) | EA000583B1 (no) |
HU (1) | HUP9901188A2 (no) |
IL (1) | IL117479A (no) |
NO (1) | NO974260L (no) |
PL (1) | PL322271A1 (no) |
WO (1) | WO1996028543A1 (no) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5718897A (en) * | 1995-06-07 | 1998-02-17 | Trustees Of Tufts College | Enhancing keratinocyte migration and proliferation |
US5830741A (en) * | 1996-12-06 | 1998-11-03 | Boehringer Mannheim Corporation | Composition for tissue dissociation containing collagenase I and II from clostridium histolyticum and a neutral protease |
AU2002355730B2 (en) * | 2001-07-27 | 2007-09-13 | Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College | Botulinum toxin in the treatment or prevention of acne |
US7364565B2 (en) | 2001-07-27 | 2008-04-29 | Ramot At Tel Aviv University Ltd. | Controlled enzymatic removal and retrieval of cells |
US7811560B2 (en) * | 2006-01-30 | 2010-10-12 | Auxilium Us Holdings, Llc | Compositions and methods for treating collagen-mediated diseases |
US8323642B2 (en) * | 2006-12-13 | 2012-12-04 | Depuy Mitek, Inc. | Tissue fusion method using collagenase for repair of soft tissue |
US20100159564A1 (en) * | 2007-11-30 | 2010-06-24 | Dwulet Francis E | Protease resistant recombinant bacterial collagenases |
US9694100B2 (en) | 2009-12-08 | 2017-07-04 | Smith & Nephew, Inc. | Enzymatic wound debriding compositions with enhanced enzymatic activity |
WO2013106510A2 (en) | 2012-01-12 | 2013-07-18 | Auxilium Pharmaceuticals, Inc. | Clostridium histolyticum enzymes and methods for the use thereof |
CN115969318A (zh) | 2017-03-01 | 2023-04-18 | 恩多风投有限公司 | 用于评估和治疗橘皮组织的装置和方法 |
KR102642381B1 (ko) | 2017-03-28 | 2024-02-28 | 엔도 벤쳐즈 리미티드 | 개선된 콜라게나제 생성 방법 |
CN109694845A (zh) * | 2018-12-25 | 2019-04-30 | 中国医学科学院北京协和医院 | 用于分离单细胞的试剂盒及其应用 |
WO2023228873A1 (ja) * | 2022-05-24 | 2023-11-30 | 国立研究開発法人国立成育医療研究センター | 肝細胞の製造方法、肝細胞の接着性改善剤、および肝細胞 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5162205A (en) * | 1986-04-26 | 1992-11-10 | Sankyo Company, Limited | Human pancreatic elastase I |
JPH0673456B2 (ja) * | 1986-04-26 | 1994-09-21 | 三共株式会社 | ヒト・膵臓エラスタ−ゼ▲i▼ |
JPH08500970A (ja) * | 1992-06-22 | 1996-02-06 | トライジェン,インコーポレーテッド | ヒストリチクス菌からのコラゲナーゼ産生に応答性の遺伝子の分子クローニング |
JP3028852B2 (ja) * | 1994-06-24 | 2000-04-04 | ロシュ ダイアグノスティックス コーポレーション | ヒストリチクス菌から得られるコラゲナーゼおよび2つの他のプロテアーゼの精製混合物 |
-
1996
- 1996-03-12 BR BR9607143A patent/BR9607143A/pt not_active Application Discontinuation
- 1996-03-12 CA CA002213723A patent/CA2213723A1/en not_active Abandoned
- 1996-03-12 CZ CZ972803A patent/CZ280397A3/cs unknown
- 1996-03-12 HU HU9901188A patent/HUP9901188A2/hu unknown
- 1996-03-12 WO PCT/EP1996/001044 patent/WO1996028543A1/de not_active Application Discontinuation
- 1996-03-12 JP JP8527270A patent/JPH11501517A/ja active Pending
- 1996-03-12 PL PL96322271A patent/PL322271A1/xx unknown
- 1996-03-12 US US08/913,396 patent/US6146626A/en not_active Expired - Fee Related
- 1996-03-12 AU AU51066/96A patent/AU702514B2/en not_active Ceased
- 1996-03-12 EP EP96907436A patent/EP0815211A1/de not_active Withdrawn
- 1996-03-12 EA EA199700241A patent/EA000583B1/ru not_active IP Right Cessation
- 1996-03-14 IL IL11747996A patent/IL117479A/xx active IP Right Grant
-
1997
- 1997-09-15 NO NO974260A patent/NO974260L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
MX9706725A (es) | 1997-11-29 |
CA2213723A1 (en) | 1996-09-19 |
AU702514B2 (en) | 1999-02-25 |
BR9607143A (pt) | 1997-11-25 |
US6146626A (en) | 2000-11-14 |
PL322271A1 (en) | 1998-01-19 |
IL117479A0 (en) | 1996-07-23 |
EP0815211A1 (de) | 1998-01-07 |
AU5106696A (en) | 1996-10-02 |
CZ280397A3 (cs) | 1998-04-15 |
EA000583B1 (ru) | 1999-12-29 |
EA199700241A1 (ru) | 1998-02-26 |
HUP9901188A2 (hu) | 1999-08-30 |
IL117479A (en) | 1999-12-22 |
WO1996028543A1 (de) | 1996-09-19 |
NO974260D0 (no) | 1997-09-15 |
JPH11501517A (ja) | 1999-02-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO974260L (no) | Nye definerte enzymblandinger for oppnåelse av celler og behandling av sår | |
DE69525151T2 (de) | Methoden zur krankheitsbehandlung unter verwendung von sertoli-zellen und allotransplantat oder xenotransplantat | |
AU8476698A (en) | Human mesenchymal stem cells from peripheral blood | |
ATE279181T1 (de) | Verwendung von 5ht-6 antagonisten zur behandlung adhd | |
DE69839815D1 (de) | Verwendung von ppar-gamma aktivatoren zur behandlung von hautkrankheiten | |
MXPA02007137A (es) | Fuente de tejido hepatico. | |
DE69430315D1 (de) | Methoden zur (ex vivo) therapie mittels peptid - bestueckten antigen - praesentierenden zellen zur aktivierung von ctl | |
ATE405657T1 (de) | Verwendung von dna-sequenzenfür männliche sterilität in transgenen pflanzen | |
DE69029257D1 (de) | Anordnung zur bestrahlung von laserstrahlen | |
DE60139077D1 (de) | System zur endotrachealen/ösophagischen stimulation vor und während eines medizinischen verfahrens | |
DE69327544T2 (de) | Mischungen zum schutz und regenierung von geweben | |
AU7437494A (en) | A novel physiologically active substance | |
ID30237A (id) | KOMBINASI PENGHAMBAT-PENGHAMBAT FBPase DAN PEMEKA-PEMEKA INSULIN UNTUK PENGOBATAN DIABETES | |
ATE238792T1 (de) | Verwendung von makroliden zur behandlung von glaukom | |
PT888271E (pt) | Derivados de benzamidina substituidos com derivados de aminoacidos e hidroxiacidos e sua utilizacao como anticoagulantes | |
WO2000028020A3 (en) | Methods for preventing cardiac hypertrophy and heart failure by inhibition of mef2 transcription factor | |
HU9300397D0 (en) | Method for modifying tropism of micor-organisms to cells, tissues and host organisms recombinant micro-organisms obtained by this way and their application in human and veterinary medicine | |
NZ506681A (en) | Disinfecting composition | |
NO850391L (no) | Preparater for kosmetisk, helse- og kroppskonserverende bruk | |
NO981818L (no) | FremgangsmÕte for Õ mobilisere hematopoetiske stamceller | |
FI913266A0 (fi) | Foerfarande foer infoerande av exogen dna i djurets somatiska och groddceller. | |
NO933742L (no) | Humant, benavledet, insulinlignende vekstfaktorbindingsprotein | |
ES2180345T3 (es) | Nuevo procedimiento para la crio-conservacion de plantas. | |
NO960766L (no) | Nytt protein og fremgangsmåte for fremstilling av dette | |
WO2004030630A3 (en) | Focal calcium channel modulation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |